| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 01/27/2011 | US20110021559 Aminopyridines useful as inhibitors of protein kinases |
| 01/27/2011 | US20110021558 Thieno-pyridine derivatives as mek inhibitors |
| 01/27/2011 | US20110021551 TREATMENT WITH OPIOID ANTAGONISTS AND mTOR INHIBITORS |
| 01/27/2011 | US20110021541 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 01/27/2011 | US20110021540 Bis-(Sulfonylamino) Derivatives in Therapy 066 |
| 01/27/2011 | US20110021531 Oxazole derivatives useful as inhibitors of faah |
| 01/27/2011 | US20110021525 P70S6 Kinase Modulators and Method of Use |
| 01/27/2011 | US20110021523 Aryl sulfonamides |
| 01/27/2011 | US20110021519 Tetrahydropteridines useful as inhibitors of protein kinases |
| 01/27/2011 | US20110021514 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 01/27/2011 | US20110021513 Modulators of interleukin-1 receptor-associated kinase |
| 01/27/2011 | US20110021504 Polymorphic form d of bazedoxifene acetate and methods of preparing same |
| 01/27/2011 | US20110021498 Indolyl- pyridone derivatives having checkpoint kinase 1 inhibitory activity |
| 01/27/2011 | US20110021497 Amino triazoles as pi3k inhibitors |
| 01/27/2011 | US20110021495 Quinazoles useful as modulators of ion channels |
| 01/27/2011 | US20110021491 Compounds, pharmaceutical composition and methods relating thereto |
| 01/27/2011 | US20110021485 Indole derivatives and their metal conjugates and uses thereof |
| 01/27/2011 | US20110021480 17-beta HSD1 and STS Inhibitors |
| 01/27/2011 | US20110021473 Inhibitors of phosphodiesterase type-iv |
| 01/27/2011 | US20110021462 Substituted tetrahydro-2h-isoquinolin-1-one derivatives, and methods for the production and use thereof |
| 01/27/2011 | US20110021449 Macrolides and uses of macrolides |
| 01/27/2011 | US20110021438 Novel compounds of the n-acylamino-amide family, compositions comprising them and uses thereof |
| 01/27/2011 | US20110021427 Biphasic calcium phosphate cement for drug delivery |
| 01/27/2011 | US20110021425 Tricyclic inhibitors of jak |
| 01/27/2011 | US20110021355 Formulation with reduced hygroscopicity |
| 01/27/2011 | US20110020901 Methods of Making Viral Particles Having a Modified Cell Binding Activity and Uses Thereof |
| 01/27/2011 | US20110020465 Methods of treatment of gout using thymus-derived compositions |
| 01/27/2011 | US20110020464 Methods of treatment using thymus-derived compositions |
| 01/27/2011 | US20110020437 Oligopeptidic compounds and uses thereof |
| 01/27/2011 | US20110020419 Osteoinductive calcium phosphates |
| 01/27/2011 | US20110020400 Probiotic bifidobacterium strains |
| 01/27/2011 | US20110020392 Process for treatment of rheumatoid arthritis, tremors/parkinson's disease, multiple sclerosis and non-viral based cancers |
| 01/27/2011 | US20110020377 Aminopyrimidines useful as inhibitors of protein kinases |
| 01/27/2011 | US20110020376 Aminopyrimidines useful as inhibitors of protein kinases |
| 01/27/2011 | US20110020372 Follistatin domain containing proteins |
| 01/27/2011 | US20110020366 Use of benzophenone derivative or salt thereof and tnf alpha inhibitor in combination and pharmaceutical composition containing the derivative or salt thereof and the inhibitor |
| 01/27/2011 | US20110020348 Pharmaceutical compositions and methods using secreted frizzled related protein |
| 01/27/2011 | US20110020338 5Imidazoquinolines and Pyrimidine Derivatives as Potent Modulators of VEGF-Driven Angiogenic Processes |
| 01/27/2011 | US20110020330 Antibody inhibitors of gdf-8 and uses thereof |
| 01/27/2011 | US20110020328 Antibody formulations |
| 01/27/2011 | US20110020321 Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor |
| 01/27/2011 | US20110020316 Composition and method to alleviate joint pain |
| 01/27/2011 | US20110020309 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergice disease |
| 01/27/2011 | US20110020284 Probiotic bifidobacterium strains |
| 01/27/2011 | US20110020273 Bispecific Immunocytokine Dock-and-Lock (DNL) Complexes and Therapeutic Use Thereof |
| 01/27/2011 | CA2768461A1 Vitamin c and vitamin k, and compositions thereof for treatment of osteolysis or prolongation of prosthetic implant |
| 01/26/2011 | EP2278004A1 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 01/26/2011 | EP2277998A1 Urate oxidase |
| 01/26/2011 | EP2277916A2 Use of antibody to M-CSF |
| 01/26/2011 | EP2277910A1 Albumin fusion proteins |
| 01/26/2011 | EP2277889A2 Fusion proteins of albumin and interferon beta |
| 01/26/2011 | EP2277888A2 Fusion proteins of albumin and erythropoietin |
| 01/26/2011 | EP2277880A1 Macrolides with VEGF transcription suppression activity |
| 01/26/2011 | EP2277876A1 Substituted pyrimidines for the treatment of cancer |
| 01/26/2011 | EP2277861A1 Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same |
| 01/26/2011 | EP2277552A1 Mnk kinase proteins and diabetes |
| 01/26/2011 | EP2277531A1 Treatment of cns damage |
| 01/26/2011 | EP2277526A1 Pharmaceutical composition with tetrahydroisohumulone |
| 01/26/2011 | EP2277522A2 Methods for increasing or decreasing bone density and identifying molecules |
| 01/26/2011 | EP2276480A2 Calycosin and analogs thereof for the treatment of estrogen receptor beta-mediated diseases |
| 01/26/2011 | EP1849795B1 1-substituted-7-( -d-glycopyranosyloxy)(aza)indole compound and pharmaceutical containing the same |
| 01/26/2011 | EP1725261B1 Use of agonists and antagonists of interleukin-33 (il-33) |
| 01/26/2011 | EP1496892B1 1h-benzo(f)indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
| 01/26/2011 | EP1446382B1 Anthranilic acid amides and their use as vegf receptor tyrosine kinase inhibitors |
| 01/26/2011 | EP1365769B1 A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis |
| 01/26/2011 | CN201719419U Novel medicated rib external fixation plaster patch |
| 01/26/2011 | CN1958027B Composition of Chinese traditional medicine for treating necrosis of femoral head, and preparation method |
| 01/26/2011 | CN1918128B Fused ring 4-oxopyrimidine derivative |
| 01/26/2011 | CN1799623B Use of No. 21 biological active peptide in preparation of medicine for preventing and treating arthritis |
| 01/26/2011 | CN101959890A Pyrrolopyrimidinecarboxamides |
| 01/26/2011 | CN101959886A Imidazo[1,2-a]pyridine-2-carboxamide derivatives, preparation thereof and application thereof in therapeutics |
| 01/26/2011 | CN101959885A Derivatives of N-heterocyclic-6-heterocyclic-imidazo[l,2- a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 01/26/2011 | CN101959884A Derivatives of 6-heterocyclic-imidazo[l,2-alpha]pyrroine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 01/26/2011 | CN101959511A Trpa1 antagonists |
| 01/26/2011 | CN101955976A Methods and immune modulatory nucleic acid compositions for preventing and treating disease |
| 01/26/2011 | CN101955505A Novel immune suppressor and composition thereof |
| 01/26/2011 | CN101954072A Use of ulinastatin in preparation of drugs for treating rheumatoid arthritis and pharmaceutical composition thereof |
| 01/26/2011 | CN101954059A Bath effervescent tablets for improving rheumatic arthritis |
| 01/26/2011 | CN101954055A Externally-applied medicament for hyperosteogeny lumbar disc herniation and preparation method thereof |
| 01/26/2011 | CN101954053A Traditional Chinese medicinal patch and preparation method thereof |
| 01/26/2011 | CN101954047A Medicine for treating prolapse of lumbar intervertebral disc |
| 01/26/2011 | CN101954045A Traditional Chinese medicinal composition for treating damp arthralgia and preparation method thereof |
| 01/26/2011 | CN101954043A Medicament for treating hyperosteogeny and preparation method thereof |
| 01/26/2011 | CN101954040A Externally-applied medicament for treating hyperosteogeny and preparation method thereof |
| 01/26/2011 | CN101954009A Application for treating arthritis |
| 01/26/2011 | CN101954005A Herbal composition for osteoarthritis |
| 01/26/2011 | CN101953993A Medicament for treating osteoporosis |
| 01/26/2011 | CN101953984A Medicinal composition for treating urarthritis, preparation method thereof, preparation thereof and use thereof |
| 01/26/2011 | CN101953977A Traditional Chinese medicine for treating diabetes gout |
| 01/26/2011 | CN101953972A Chinese medicinal compound prescription having effect of resisting osteoporosis and preparation method and application thereof |
| 01/26/2011 | CN101953941A Chinese medicinal liquor for treating femoral head necrosis |
| 01/26/2011 | CN101953940A Traditional Chinese medicine having function of tonifying kidney, invigorating blood circulation and relieving pain, preparation method and quality specification thereof |
| 01/26/2011 | CN101953926A Oral Chinese medicinal composition for treating gout |
| 01/26/2011 | CN101953908A Chinese medicinal composition for treating pain in waist and lower extremities and preparation method thereof |
| 01/26/2011 | CN101953907A Medicinal composition for treating rheumatoid arthritis and preparation method and application thereof |
| 01/26/2011 | CN101953906A Medicinal composition for treating rheumatoid arthritis, preparation method and application |
| 01/26/2011 | CN101953905A Micropowder medicament for treating cervical and lumbar intervertebral disc herniation, osteoproliferation and proliferation of mammary gland and preparation method thereof |
| 01/26/2011 | CN101953881A Anti-osteoporosis traditional Chinese medicinal preparation and preparation method thereof |
| 01/26/2011 | CN101953877A Medicinal composition for treating osteoporosis |
| 01/26/2011 | CN101953842A Application of syringin in preparation of medicine for treating acute gout |